CELIX PHARMA LTD
12 CONSTANCE STREET, INTERNATIONAL HOUSE, LONDON  E16 2DQ- Active
- Private Limited Company
- Company No. 12474195
- Last Updated: 01 Mar 2024
Company Profile
CELIX PHARMA LTD was incorporated on Thursday, February 20, 2020 as a Private Limited Company with registered address in LONDON. CELIX PHARMA LTD has the status: Active and it's listed in the following category: Manufacture of pharmaceutical preparations. This Private Limited Company has been operating for 4 years 8 months and 17 days.
Name | CELIX PHARMA LTD |
---|---|
Company number | 12474195 |
Company type | Private Limited Company |
Incorporation date | 20 Feb 2020 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
12 CONSTANCE STREET INTERNATIONAL HOUSE LONDON E16 2DQ |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr. Shantreddy Channareddy Soogareddy Nationality: Indian |
Dates: Monday, June 1, 2020 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Mr. Subir Kohli Nationality: British |
Dates: Monday, June 1, 2020 - present
ownership of shares 50 to 75 percent
voting rights 50 to 75 percent
right to appoint and remove directors
|
Mrs Amrita Kohli Nationality: British |
Dates: Thursday, February 20, 2020 - Monday, June 1, 2020
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | MICRO ENTITY |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2024, (52 days left) |
Latest accounts | 31 March 2023 |
Next confirmation statement due | 20 March 2021 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against CELIX PHARMA LTD.
Previous Names
Name | Change Date |
---|---|
CELIX PHARMA LTD | 20 Feb 2020 |